These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36034445)

  • 1. Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.
    Long C; Tang Y; Huang J; Liu S; Xing Z
    Front Endocrinol (Lausanne); 2022; 13():975468. PubMed ID: 36034445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events.
    Sheng L; Yang G; Chai X; Zhou Y; Sun X; Xing Z
    Front Endocrinol (Lausanne); 2024; 15():1323571. PubMed ID: 38419951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.
    Sun B; He F; Gao Y; Zhou J; Sun L; Liu R; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jun; 64(3):536-543. PubMed ID: 30868413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visit-to-Visit Variations in Fasting Plasma Glucose and HbA
    Li TC; Yang CP; Tseng ST; Li CI; Liu CS; Lin WY; Hwang KL; Yang SY; Chiang JH; Lin CC
    Diabetes Care; 2017 Sep; 40(9):1210-1217. PubMed ID: 28705834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between long-term glycemic variability and cognitive function in middle-aged and elderly patients with type 2 diabetes mellitus: a retrospective study.
    Ding J; Shi Q; Tao Q; Su H; Du Y; Pan T; Zhong X
    PeerJ; 2023; 11():e16698. PubMed ID: 38144199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes.
    Tang X; Zhong J; Zhang H; Luo Y; Liu X; Peng L; Zhang Y; Qian X; Jiang B; Liu J; Li S; Chen Y
    Cardiovasc Diabetol; 2019 Apr; 18(1):50. PubMed ID: 30992008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).
    Li L; Yang T; Xue Y; Ruan P; Du J; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2022 Jan; 39(1):421-429. PubMed ID: 34757600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Both Short-term and Long-term Glycemic Variability With the Development of Microalbuminuria in the ACCORD Trial.
    Okuno T; Vansomphone A; Zhang E; Zhou H; Koska J; Reaven P; Zhou JJ
    Diabetes; 2023 Dec; 72(12):1864-1869. PubMed ID: 37725902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis.
    Wang T; Zhang X; Liu J
    Horm Metab Res; 2022 Feb; 54(2):84-93. PubMed ID: 35130569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living Alone Is Not Associated With Cardiovascular Events and Hypoglycemia in Patients With Type 2 Diabetes Mellitus.
    Zhu Z; Peng Z; Xing Z
    Front Public Health; 2022; 10():883383. PubMed ID: 35669761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac autonomic neuropathy modified the association between obesity and hypoglycemia in type 2 diabetes.
    Zhang W; Huang Y; Zhou Z; Xie P; Zhuang X; Jiang J; Liao X
    Endocrine; 2024 Sep; 85(3):1213-1221. PubMed ID: 38904908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis.
    Dholariya S; Dutta S; Singh R; Parchwani D; Sonagra A; Kaliya M
    Expert Opin Pharmacother; 2023; 24(18):2187-2198. PubMed ID: 37817422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.
    Davidson JA; Liebl A; Christiansen JS; Fulcher G; Ligthelm RJ; Brown P; Gylvin T; Kawamori R
    Clin Ther; 2009 Aug; 31(8):1641-51. PubMed ID: 19808125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.
    Klein KR; Franek E; Marso S; Pieber TR; Pratley RE; Gowda A; Kvist K; Buse JB
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34819298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.